Citations

Institution: Mayo Clinic Clear

Showing 10 of 108162 citations.

Pathology and Genetics of Syndromic Gastric Polyps
Wood, Laura D. , Offerhaus, G. Johan A. , Lam‐Himlin, Dora , Giardiello, Francis M., Lam-Himlin, Dora, Brosens, Lodewijk A.A. , Arnold, Christina A. , Montgomery, Elizabeth Anne

International Journal of Surgical Pathology | December 31, 2015 | Volume: 24 | Issue: 3 | Pages: 185-199

10.1177/1066896915620013 | PMID 26721304 Get It

Gastric polyps are found in 1% to 4% of patients undergoing gastroscopy. The vast majority are sporadic, but some gastric polyps indicate an underlying syndrome. Gastric polyps can manifest in each of the gastrointestinal polyposis syndromes, including the recently described gastric adenocarcinoma and proximal polyposis of the stomach syndrome. In addition, gastric polyps occur in Lynch syndrome and in a few rare conditions that are not primarily gastrointestinal. While some of these syndromes are clearly associated with an increased risk of gastric cancer, others are not. Interestingly, even in disorders with a well-established risk of gastric cancer, the neoplastic potential and the precursor status of these gastric polyps are not always clear. Although rare, recognition of syndromic gastric polyps is important for individual patient management. These conditions also serve as important models to study gastric homeostasis and gastric tumorigenesis.
Uptake and Documentation of the Use of an Encounter Decision Aid in Usual Practice
Inselman, Jonathan , Castañeda-Guarderas, Ana, Gionfriddo, Michael R. , Zeballos‐Palacios, Claudia , Shah, Nilay D. , Montori, Víctor M. , Branda, Megan, Zeballos-Palacios, Claudia L, Morris, Megan M, LeBlanc, Annie , Branda, Megan E. , Morris, Megan M. , Montori, Victor M

Medical Decision Making | December 31, 2015 | Volume: 36 | Issue: 4 | Pages: 557-561

10.1177/0272989x15618175 | PMID 26721257 Get It

The High Risk of Low Distal Flow
Meschia, James F.

JAMA Neurology | December 31, 2015 | Volume: 73 | Issue: 2 | Pages: 157

10.1001/jamaneurol.2015.3885 | PMID 26720910 Get It

Response to Letter Regarding Article, “Prospective Randomized Trial of Moderately Strenuous Aerobic Exercise After an Implantable Cardioverter Defibrillator”
Dougherty, Cynthia M. , Glenny, Robb W. , Burr, Robert L. , Flo, Gayle L. , Kudenchuk, Peter J.

Circulation | December 31, 2015 | Volume: 132 | Issue: 24 | Pages: No page available

10.1161/circulationaha.115.018778 | PMID 26667103 Get It

The role of postmastectomy radiotherapy in clinically node-positive, stage II-III breast cancer patients with pathological negative nodes after neoadjuvant chemotherapy: an analysis from the NCDB
Liu, Jieqiong , Mao, Kai, Jiang, Wen , Kim, Betty Y.S. , Liu, Qiang , Jacobs, Lisa K. , Jiang, Shuai , Chen, Kai , Jiang, Wen , Kim, Betty Y S

Oncotarget | December 31, 2015 | Volume: 7 | Issue: 17 | Pages: 24848-24859

10.18632/oncotarget.6664 | PMID 26709538 Get It

Nonsteroidal Anti‐inflammatory Drugs and Risk of Incident Heart Failure: A Systematic Review and Meta‐analysis of Observational Studies
Ungprasert, Patompong , Srivali, Narat , Thongprayoon, Charat , Srivali, Narat

Clinical Cardiology | December 31, 2015 | Volume: 39 | Issue: 2 | Pages: 111-118

10.1002/clc.22502 | PMID 26720629 Get It

ABSTRACTBackgroundThe association between the development of heart failure (HF) and use of nonsteroidal anti‐inflammatory drugs (NSAIDs) is not well established.HypothesisUse of NSAIDs may increase the risk of incident HF.MethodsWe conducted a systematic review and meta‐analysis of observational studies that reported odds ratio, relative risk, hazard ratio, or standardized incidence ratio comparing risk of incident HF in NSAID users vs nonusers. Pooled risk ratios (RR) and 95% confidence intervals (CI) for all NSAIDs and both subclasses (conventional NSAIDs and highly selective cyclooxygenase‐2 inhibitors [COXIBs]) were calculated using a random‐effect, generic inverse variance method.ResultsSeven studies with 7 543 805 participants were identified and included in our data analysis. Use of NSAIDs was associated with a significantly higher risk of developing HF, with a pooled RR of 1.17 (95% CI: 1.01‐1.36). Subgroup analysis showed a significantly elevated risk among users of conventional NSAIDs (RR: 1.35, 95% CI: 1.15‐1.57) but not users of COXIBs (RR: 1.03, 95% CI: 0.92‐1.16).ConclusionsA significantly elevated risk of incident HF was observed among users of NSAIDs.
Sinus Node Dysfunction Is Associated With Higher Symptom Burden and Increased Comorbid Illness: Results From the ORBIT‐AF Registry
Kim, Sung Hee, Piccini, Jonathan P. , Reiffel, James A. , Thomas, Laine , Chang, Paul, Fonarow, Gregg C. , Go, Alan S. , Mahaffey, Kenneth W. , Kowey, Peter R. , Jackson, Larry R. , Gersh, Bernard J. , Naccarelli, Gerald V. , Freeman, James V. , Peterson, Eric D.

Clinical Cardiology | December 31, 2015 | Volume: 39 | Issue: 2 | Pages: 119-125

10.1002/clc.22504 | PMID 26720750 Get It

ABSTRACTBackgroundPatients with sinus node dysfunction (SND) have increased risk of atrial tachyarrhythmias, including atrial fibrillation (AF). To date, treatment patterns and outcomes of patients with SND and AF have not been well described.HypothesisPatients with SND and AF have higher risk of adverse cardiovascular outcomes.MethodsSinus node dysfunction was defined clinically, based on treating physician. Treatment patterns were described and logistic regression analysis performed to assess outcomes.ResultsOverall, 1710 (17.7%) out of 9631 patients had SND at enrollment. Patients with SND and AF had increased comorbid medical illnesses, more severe symptoms (European Heart Rhythm Association class IV: 17.5% vs 13.9%; P = 0.0007), and poorer quality of life (median 12‐month Atrial Fibrillation Effect on Quality of Life score: 79.6 vs 85.2; P = 0.0008). There were no differences in AF management strategy between patients with SND and those without (rate control, 69.7% vs 67.7%; rhythm control, 30.0% vs 32.0%; P = 0.11). After adjustment, patients with SND were more likely than those without SND to progress from paroxysmal AF at baseline to persistent or permanent AF at any follow‐up, or persistent AF at baseline to permanent AF at any follow‐up (odds ratio: 1.23, 95% confidence interval: 1.01‐1.49, P = 0.035). However, there was no association between SND and major risk‐adjusted outcomes.ConclusionsSinus node dysfunction is present in 1 of 6 patients with AF and is associated with increased comorbidities and higher symptom burden. However, SND is not associated with an increase in major risk‐adjusted outcomes.
Comprehensive nucleosome mapping of the human genome in cancer progression
Druliner, Brooke R. , Vera, Daniel L. , Johnson, Ruth, Ruan, Xiaoyang , Apone, Lynn M., Dimalanta, Eileen T. , Stewart, Fiona J., Boardman, Lisa, Dennis, Jonathan H. , Apone, Lynne, Boardman, Lisa

Oncotarget | December 31, 2015 | Volume: 7 | Issue: 12 | Pages: 13429-13445

10.18632/oncotarget.6811 | PMID 26735342 Get It

Variability of Brain Death Policies in the United States
Greer, David M. , Wang, Hilary H., Robinson, Jennifer D. , Varelas, Panayiotis N. , Henderson, Galen V., Wijdicks, Eelco F. M. , Greer, David Matthew

JAMA Neurology | December 31, 2015 | Volume: 73 | Issue: 2 | Pages: 213

10.1001/jamaneurol.2015.3943 | PMID 26719912 Get It